ASCO Direct™ Highlight: 2021 Official Annual Meeting Review is organized by Binaytara Foundation (BTF) and will be held from Jul 24 - 25, 2021 at Crowne Plaza Seattle Downtown, Seattle, Washington, United States of America.
Target Audience:
• Hematologists/Oncologists
• Oncology Nurse Practitioners
• Oncology Pharmacists
• Oncology Physician Assistants
• Oncology Fellows/Residents
• Oncology Nurses
• Researchers and others involved in the care of cancer patients
Description:
ASCO Direct™ Highlights: 2021 Official Annual Meeting Review, an officially licensed program of the American Society of Clinical Oncology® (ASCO®) is the 9th annual conference being organized by the Binaytara Foundation and features some of the most well-known experts in the field of hematology and oncology. A number of potentially practice-changing abstracts are expected to be presented during the 2021 ASCO Annual Meeting in June, 2021 (ASCO2021). Expert faculty will place abstract findings from ASCO2021 into clinical context and discuss how the results may change the current standard of care.
Conference highlights:
• Innovative and integrated learning environment.
• Audience response system
• Core competencies covered include patient care/patient-centered care, medical knowledge, system-based practice, and practice-based learning and improvement.
• Opportunities to network with colleagues and interact with faculties; enduring materials allow learners opportunities to learn at their convenience.
• Program topics can immediately be applied to clinical practice.
Learning Objectives:
At the conclusion of the activity, participants will be able to:
• Discuss new and updated treatment options for patients with hematologic malignancies and solid tumors
• Identify side effects, indications, and contra-indications of therapies used to diagnose and treat cancers
• Explain how to effectively manage side-effects associated with cancer treatment
• Review abstracts presented at ASCO® 2021 and discuss their application in clinical settings
Updates in lymphoma – 30 minutes
Updates in CLL – 30 minutes
Rapid fire Q&A – 15 minutes
Management of multiple myeloma – 30 minutes
Acute leukemia – new updates – 30 minutes
Rapid fire Q&A – 15 minutes
Recent updates in NSCLC – 30 minutes
Small cell lung cancer - 30 minutes
Rapid fire Q&A – 15 minutes
Non-metastatic breast cancer – 30 minutes
Metastatic breast cancer - 30 minutes
Gynecologic malignancies – 30 minutes
Q & A – 15 minutes
Sarcoma updates – 30 minutes
Brain tumor updates – 30 minutes
Q & A – 15 minutes
Updates in management of colon cancer – 30 minutes
Management of upper GI malignancies – 30 minutes
Pancreatic cancer and neuroendocrine carcinoma – 30 minutes
Rapid fire Q&A – 15 minutes
Bladder cancer and prostate cancer – newer updates – 30 minutes
Head and neck cancer – 30 minutes
Skin cancers – new updates – 30 minutes
Discussion – 15 minutes
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved